Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1938 1
1950 2
1951 3
1953 1
1954 2
1955 3
1956 3
1957 3
1958 4
1959 7
1960 6
1961 7
1962 12
1963 17
1964 19
1965 22
1966 33
1967 24
1968 29
1969 24
1970 26
1971 25
1972 38
1973 38
1974 52
1975 40
1976 52
1977 42
1978 55
1979 56
1980 56
1981 58
1982 95
1983 83
1984 122
1985 126
1986 128
1987 143
1988 156
1989 148
1990 160
1991 145
1992 160
1993 169
1994 173
1995 224
1996 198
1997 192
1998 232
1999 244
2000 273
2001 228
2002 241
2003 219
2004 247
2005 267
2006 279
2007 296
2008 318
2009 316
2010 337
2011 329
2012 386
2013 449
2014 405
2015 393
2016 402
2017 399
2018 429
2019 510
2020 589
2021 606
2022 553
2023 500
2024 184

Text availability

Article attribute

Article type

Publication date

Search Results

11,742 results

Results by year

Filters applied: . Clear all
Page 1
TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy.
Yamada S, Ko T, Ito M, Sassa T, Nomura S, Okuma H, Sato M, Imasaki T, Kikkawa S, Zhang B, Yamada T, Seki Y, Fujita K, Katoh M, Kubota M, Hatsuse S, Katagiri M, Hayashi H, Hamano M, Takeda N, Morita H, Takada S, Toyoda M, Uchiyama M, Ikeuchi M, Toyooka K, Umezawa A, Yamanishi Y, Nitta R, Aburatani H, Komuro I. Yamada S, et al. Among authors: yamada t. Sci Adv. 2023 Apr 14;9(15):eade7047. doi: 10.1126/sciadv.ade7047. Epub 2023 Apr 14. Sci Adv. 2023. PMID: 37058558 Free PMC article.
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: yamada t. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
Tracheal leiomyoma.
Watanabe A, Fujii M, Sano T, Ikegami S, Kamei J, Kojima S, Satake Y, Yamada T. Watanabe A, et al. Among authors: yamada t. QJM. 2023 Jul 28;116(7):563-565. doi: 10.1093/qjmed/hcad044. QJM. 2023. PMID: 36944268 No abstract available.
A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma.
Ishihara M, Nishida Y, Kitano S, Kawai A, Muraoka D, Momose F, Harada N, Miyahara Y, Seo N, Hattori H, Takada K, Emori M, Kakunaga S, Endo M, Matsumoto Y, Sasada T, Sato E, Yamada T, Matsumine A, Nagata Y, Watanabe T, Kageyama S, Shiku H. Ishihara M, et al. Among authors: yamada t. Int J Cancer. 2023 Jun 15;152(12):2554-2566. doi: 10.1002/ijc.34453. Epub 2023 Feb 17. Int J Cancer. 2023. PMID: 36727538 Clinical Trial.
Prenatal diagnosis of bone dysplasias.
Nishimura G, Handa A, Miyazaki O, Tsujioka Y, Murotsuki J, Sawai H, Yamada T, Kozuma Y, Takahashi Y, Ozawa K, Pooh R, Sase M. Nishimura G, et al. Among authors: yamada t. Br J Radiol. 2023 Jul;96(1147):20221025. doi: 10.1259/bjr.20221025. Br J Radiol. 2023. PMID: 37351952 Review.
Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma.
Yamada T, Fujiwara N, Kubota N, Matsushita Y, Nakatsuka T, Kurosaki S, Minami T, Tateishi R, Ichida A, Arita J, Hasegawa K, Koike K, Fujishiro M, Nakagawa H. Yamada T, et al. Hepatol Commun. 2023 Jul 17;7(8):e0209. doi: 10.1097/HC9.0000000000000209. eCollection 2023 Aug 1. Hepatol Commun. 2023. PMID: 37471053 Free PMC article.
Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer.
Kawachi H, Yamada T, Tamiya M, Negi Y, Goto Y, Nakao A, Shiotsu S, Tanimura K, Takeda T, Okada A, Harada T, Date K, Chihara Y, Hasegawa I, Tamiya N, Ishida M, Katayama Y, Morimoto K, Iwasaku M, Tokuda S, Kijima T, Takayama K. Kawachi H, et al. Among authors: yamada t. JAMA Netw Open. 2023 Jul 3;6(7):e2322915. doi: 10.1001/jamanetworkopen.2023.22915. JAMA Netw Open. 2023. PMID: 37432682 Free PMC article.
TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy.
Yamada T, Tatematsu M, Takasuga S, Fuchimukai A, Yamagata K, Seki S, Kuba K, Yoshida H, Taniuchi I, Bernhardt G, Shibuya K, Shibuya A, Yamada T, Ebihara T. Yamada T, et al. J Exp Med. 2023 Jul 3;220(7):e20222005. doi: 10.1084/jem.20222005. Epub 2023 Apr 10. J Exp Med. 2023. PMID: 37036426 Free PMC article.
11,742 results
You have reached the last available page of results. Please see the User Guide for more information.